Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: A single center experience from China

International Journal of Hematology

Volumn 88, Issue 5, 2009, Pages 530-535

  Bai, Jie ^a   Xue, Yangping ^a   Ye, Lei ^a   Yao, Jianfeng ^a   Zhou, Chunlin ^a   Shao, Zonghong ^a   Qian, Linsheng ^a   Yang, Renchi ^a   Li, Haiyan ^a   Zhang, Hongyun ^a   Zheng, Yizhou ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Leukaemia; Malignance; Myelofibrosis with myeloid metaplasia; Polycythemia vera; Prognosis; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; ALPHA2B INTERFERON; HEMOGLOBIN; HYDROXYUREA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHINA; CLINICAL EVALUATION; DEATH; DISEASE COURSE; EVOLUTION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; OVERALL SURVIVAL; PATIENT REFERRAL; PHLEBOTOMY; POLYCYTHEMIA VERA; RISK FACTOR; SPLENOMEGALY; THROMBOEMBOLISM; THROMBOSIS; AGE; BLOOD; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 64249163967     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0188-y     Document Type: Article

References (18)

1. CS Chim YL Kwong PT Chan R Liang 1997 Polycythemia vera in Chinese patients: thirty-six years of experience Am J Hematol 56 59 62 10.1002/(SICI)1096-8652(199709)56:1<59::AID-AJH12>3.0.CO;2-Y
2. Gruppo Italiano Studio Policitemia 1995 Polycythemia vera: the natural history of 1213 patients followed for 20 years Ann Intern Med 123 656 64 10.1001/archinte.123.6.656
3. 32P between 1969 and 1981 Semin Hematol 34 6 16
4. F Passamonti L Malabarba E Orlandi 2003 Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia Haematologica 88 13 8
5. E Chievitz T Thiede 1962 Complication and causes of death in polycythemia vera Acta Med Scand 172 513 23
6. PD Berk JD Goldberg PB Donovan SM Fruchtman NT Berlin LR Wasserman 1986 Therapeutic recommendations in polycytheia vera based on polycythemia vera study group protocols Semin Hematol 23 132 43
7. C Rozman M Giralt E Feliu D Rubio MT Cortes 1991 Life expectancy of patients with chronic nonleukemic myeloproliferative disorders Cancer 67 2658 63 10.1002/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C
8. Y Najean JD Rain 1997 Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years Blood 90 3370 7
9. Y Najean C Dresch JD Rain 1994 The very-long-term course of polycythemia: a complement to the previously published data of the Polycythemia vera Study Group Br J Haematol 86 233 5 10.1111/j.1365-2141.1994.tb03289.x
10. A Weinfeld B Swolin J Westin 1994 Acute leukemia after hydroxyurea therapy in polycythemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications Eur J Haematol 52 134 9
11. G Finazzi M Ruggeri F Rodeghiero T Barbui 2000 Second malignancies in patients with essential thrombocythemia treated with busulphan and hydroxyurea: long-term follow up of a randomized clinical trial Br J Haematol 110 577 83 10.1046/j.1365-2141.2000.02188.x
12. E Lengfelder U Berger R Hehlman 2000 Interferon in the treatment of polycythemia vera Ann Hematol 79 103 9 10.1007/s002770050563
13. JJ Kiladjian B Cassinat P Turlure 2006 High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a Blood 108 2037 40 10.1182/blood-2006-03-009860
14. Polycythemia vera, Chronic idiopathic myelofibrosis, Acute myeloid leukaemia. In Pierre R, Imbert M, Thiele J, Brunning RD, Matutes E, Harris NL, et al., editors. World Health Organization classification of Tumours. lyon: IARC; 2001. pp. 32-75.
15. Y Najean P Mugnier C Dresch JD Rain 1987 Polycythemia vera in young people: an analysis of 58 cases diagnosed before 40 years Br J Haematol 67 285 91 10.1111/j.1365-2141.1987.tb02349.x
16. M Di Nisio T Barbui L Di Gennaro 2007 European collaboration on low-dose aspirin in polycythemia vera (ECLAP) investiagtors. The haematocrit and platelet target in polycythemia vera Br J Haematol 136 249 59 10.1111/j.1365-2141.2006. 06430.x
17. R Landolfi R Marchioli J Kutti 2004 European collaboration on low-dose aspirin in polycythemia vera investigators. Efficacy and safety of low-dose aspirin in polycythemia vera N Engl J Med 350 114 24 10.1056/NEJMoa035572
18. G Finazzi V Caruso R Marchioli 2005 ECLAP investigators. Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study Blood 105 2664 70 10.1182/blood-2004-09-3426